Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
At present, United States market is mainly occupied by own brands. The domestic enterprise technology still keeps leading level.
Technology advantage is a key factor for domestic enterprise to make up most shares.
The report offers detailed coverage of Levothyroxine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Levothyroxine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Levothyroxine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.
First, this report covers the present status and the future prospects of the global Levothyroxine market for 2015-2027.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
At the same time, we classify Levothyroxine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Slice in solid
In bottles for injection
Market by Application
Hospitals
Chemist's shops
Other medical institutions
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Levothyroxine market for the forecast period 2021 - 2027?
• What are the driving forces in the Levothyroxine market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Levothyroxine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?